Florestan Koll

Papers

Total Citations

H-Index

About

Florestan Koll is a urologic researcher whose work centers on improving outcomes in genitourinary cancers, with a particular focus on upper tract urothelial carcinoma (UTUC) and prostate cancer. His major contributions include critically evaluating the diagnostic accuracy of pre-operative biopsies in UTUC, revealing a significant discordance between biopsy results and final pathology—a finding that challenges current clinical assumptions and underscores the need for refined surgical planning. In prostate cancer, Koll has investigated the prognostic significance of lymphovascular and perineural invasion in radical prostatectomy specimens, demonstrating their strong association with biochemical recurrence. His most cited study, published in 2021, has accumulated 12 citations and provides essential data on prognostic factors and oncologic outcomes in UTUC. A subsequent 2024 study, with 7 citations, further solidifies his impact in the field. Koll’s work is characterized by rigorous database analysis and a clear translational focus, offering actionable insights for urologists and oncologists. His research not only advances the understanding of tumor biology but also directly informs clinical decision-making, making him a valuable voice in contemporary urologic oncology.